Your browser doesn't support javascript.
loading
A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
van Beekhuizen, Heleen J; Stefanovic, Vedran; Schwickert, Alexander; Henrich, Wolfgang; Fox, Karin A; MHallem Gziri, Mina; Sentilhes, Loïc; Gronbeck, Lene; Chantraine, Frederic; Morel, Oliver; Bertholdt, Charline; Braun, Thorsten; Rijken, Marcus J; Duvekot, Johannes J.
Afiliação
  • van Beekhuizen HJ; Department of Gynecological Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Stefanovic V; Department of Obstetrics and Gynecology, Fetomaternal Medical Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Schwickert A; Department of Obstetrics and Department of Experimental Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Henrich W; Department of Obstetrics and Department of Experimental Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Fox KA; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA.
  • MHallem Gziri M; Department of Obstetrics, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Sentilhes L; Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France.
  • Gronbeck L; Department of Obstetrics, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
  • Chantraine F; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire de Liège, Site CHR Citadelle, Liège, Belgium.
  • Morel O; Nancy Regional and University Hospital Center (CHRU, Women's Division, Université de Lorraine, Nancy, France.
  • Bertholdt C; Diagnosis and International Adaptive Imaging (IADI) Unit, Inserm, Université de Lorraine, Nancy, France.
  • Braun T; Nancy Regional and University Hospital Center (CHRU, Women's Division, Université de Lorraine, Nancy, France.
  • Rijken MJ; Diagnosis and International Adaptive Imaging (IADI) Unit, Inserm, Université de Lorraine, Nancy, France.
  • Duvekot JJ; Department of Obstetrics and Department of Experimental Obstetrics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Acta Obstet Gynecol Scand ; 100 Suppl 1: 12-20, 2021 03.
Article em En | MEDLINE | ID: mdl-33483943
ABSTRACT

INTRODUCTION:

Management options for women with placenta accreta spectrum (PAS) comprise termination of pregnancy before the viable gestational age, leaving the placenta in situ for subsequent reabsorption of the placenta or delayed hysterectomy, manual removal of placenta after vaginal delivery or during cesarean section, focal resection of the affected uterine wall, and peripartum hysterectomy. The aim of this observational study was to describe actual clinical management and outcomes in PAS in a large international cohort. MATERIAL AND

METHODS:

Data from women in 15 referral centers of the International Society of PAS (IS-PAS) were analyzed and correlated with the clinical classification of the IS-PAS From Grade 1 (no PAS) to Grade 6 (invasion into pelvic organs other than the bladder). PAS was usually diagnosed antenatally and the operators performing ultrasound rated the likelihood of PAS on a Likert scale of 1 to 10.

RESULTS:

In total, 442 women were registered in the database. No maternal deaths occurred. Mean blood loss was 2600 mL (range 150-20 000 mL). Placenta previa was present in 375 (84.8%) women and there was a history of a previous cesarean in 329 (74.4%) women. The PAS likelihood score was strongly correlated with the PAS grade (P < .001). The mode of delivery in the majority of women (n = 252, 57.0%) was cesarean hysterectomy, with a repeat laparotomy in 20 (7.9%) due to complications. In 48 women (10.8%), the placenta was intentionally left in situ, of those, 20 (41.7%) had a delayed hysterectomy. In 26 women (5.9%), focal resection was performed. Termination of pregnancy was performed in 9 (2.0%), of whom 5 had fetal abnormalities. The placenta could be removed in 90 women (20.4%) at cesarean, and in 17 (3.9%) after vaginal delivery indicating mild or no PAS. In 34 women (7.7%) with an antenatal diagnosis of PAS, the placenta spontaneously separated (false positives). We found lower blood loss (P < .002) in 2018-2019 compared with 2009-2017, suggesting a positive learning curve.

CONCLUSIONS:

In referral centers, the most common management for severe PAS was cesarean hysterectomy, followed by leaving the placenta in situ and focal resection. Prenatal diagnosis correlated with clinical PAS grade. No maternal deaths occurred.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equipe de Assistência ao Paciente / Placenta Acreta / Procedimentos Cirúrgicos Obstétricos / Tratamento Conservador Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equipe de Assistência ao Paciente / Placenta Acreta / Procedimentos Cirúrgicos Obstétricos / Tratamento Conservador Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2021 Tipo de documento: Article